Form 6-K WuXi PharmaTech (Cayman) For: May 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
WuXi PharmaTech (WX) Tops Q1 EPS by 4c; Guides Q2 EPS Below Views, Updates FY15 GAAP EPS Outlook
May 13, 2015 4:32 PM EDTWuXi PharmaTech (NYSE: WX) reported Q1 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $180 million versus the consensus estimate of $174.15 million.
WuXi PharmaTech sees Q2 2015 EPS of $0.38 - $0.40, versus the consensus of $0.42. WuXi PharmaTech sees Q2 2015... More
